Another study observed that exosomal miR-320a, derived from CAFs, has lower expression in endometrial cancer cells and tissues: it targets hypoxia-inducible factor 1 subunit alpha (HIF1α), which reduces vascular endothelial growth factor a (VEGFA) expression, inhibiting cell proliferation [154]. This evidence concerns the gene HIF1A and endometrial cancer.